Medcorp Limited (TTSE:MED)

Medcorp Statistics

Total Valuation

Medcorp has a market cap or net worth of TTD 344.52 million. The enterprise value is 415.27 million.

Market Cap	344.52M
Enterprise Value	415.27M

Important Dates

The next estimated earnings date is Thursday, May 28, 2026.

Earnings Date	May 28, 2026
Ex-Dividend Date	Feb 13, 2026

Share Statistics

Medcorp has 7.83 million shares outstanding. The number of shares has increased by 2.75% in one year.

Current Share Class	7.83M
Shares Outstanding	7.83M
Shares Change (YoY)	+2.75%
Shares Change (QoQ)	-8.53%
Owned by Insiders (%)	82.96%
Owned by Institutions (%)	n/a
Float	1.33M

Valuation Ratios

The trailing PE ratio is 18.57.

PE Ratio	18.57
Forward PE	n/a
PS Ratio	2.83
PB Ratio	3.48
P/TBV Ratio	3.48
P/FCF Ratio	15.13
P/OCF Ratio	14.05
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.14, with an EV/FCF ratio of 18.24.

EV / Earnings	22.84
EV / Sales	3.41
EV / EBITDA	10.14
EV / EBIT	16.77
EV / FCF	18.24

Financial Position

The company has a current ratio of 2.09, with a Debt / Equity ratio of 1.02.

Current Ratio	2.09
Quick Ratio	1.84
Debt / Equity	1.02
Debt / EBITDA	2.62
Debt / FCF	4.44
Interest Coverage	5.14

Financial Efficiency

Return on equity (ROE) is 21.29% and return on invested capital (ROIC) is 11.86%.

Return on Equity (ROE)	21.29%
Return on Assets (ROA)	6.11%
Return on Invested Capital (ROIC)	11.86%
Return on Capital Employed (ROCE)	11.67%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	121.70M
Profits Per Employee	18.18M
Employee Count	1
Asset Turnover	0.53
Inventory Turnover	6.96

Taxes

In the past 12 months, Medcorp has paid 2.24 million in taxes.

Income Tax	2.24M
Effective Tax Rate	10.96%

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	45.21
200-Day Moving Average	n/a
Relative Strength Index (RSI)	0.20
Average Volume (20 Days)	25

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medcorp had revenue of TTD 121.70 million and earned 18.18 million in profits. Earnings per share was 2.37.

Revenue	121.70M
Gross Profit	64.52M
Operating Income	22.31M
Pretax Income	20.42M
Net Income	18.18M
EBITDA	38.51M
EBIT	22.31M
Earnings Per Share (EPS)	2.37

Balance Sheet

The company has 30.30 million in cash and 101.05 million in debt, with a net cash position of -70.75 million or -9.04 per share.

Cash & Cash Equivalents	30.30M
Total Debt	101.05M
Net Cash	-70.75M
Net Cash Per Share	-9.04
Equity (Book Value)	98.90M
Book Value Per Share	13.80
Working Capital	37.84M

Cash Flow

In the last 12 months, operating cash flow was 24.52 million and capital expenditures -1.76 million, giving a free cash flow of 22.76 million.

Operating Cash Flow	24.52M
Capital Expenditures	-1.76M
Depreciation & Amortization	16.20M
Net Borrowing	-15.90M
Free Cash Flow	22.76M
FCF Per Share	2.91

Margins

Gross margin is 53.01%, with operating and profit margins of 18.33% and 14.94%.

Gross Margin	53.01%
Operating Margin	18.33%
Pretax Margin	16.78%
Profit Margin	14.94%
EBITDA Margin	31.64%
EBIT Margin	18.33%
FCF Margin	18.70%

Dividends & Yields

This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 4.55%.

Dividend Per Share	2.00
Dividend Yield	4.55%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	43.07%
Buyback Yield	-2.75%
Shareholder Yield	1.80%
Earnings Yield	5.28%
FCF Yield	6.61%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4